• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国成人医院获得性肺炎管理与抗生素治疗指南

Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia.

作者信息

Choi Hayoung, Min Kyung Hoon, Lee Young Seok, Chang Youjin, Lee Bo Young, Oh Jee Youn, Baek Ae-Rin, Lee Jongmin, Jeon Kyeongman

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea.

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.

出版信息

Tuberc Respir Dis (Seoul). 2025 Jan;88(1):69-89. doi: 10.4046/trd.2024.0135. Epub 2024 Oct 11.

DOI:10.4046/trd.2024.0135
PMID:39391954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704733/
Abstract

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are correlated with high morbidity and mortality rates. Guidelines that consider local epidemiologic data are fundamental for identifying optimal treatment strategies. However, Korea has no HAP/VAP guidelines. This study was conducted by a committee of nine experts from the Korean Academy of Tuberculosis and Respiratory Diseases Respiratory Infection Study Group using the results of Korean HAP/VAP epidemiologic studies. Eleven key questions for HAP/VAP diagnosis and treatment were addressed. The Convergence of Opinion on Suggestions and Evidence (CORE) process was used to derive suggestions, and evidence levels and recommendation grades were in accordance with the Grading of Recommendations Assessment Development and Evaluation (GRADE) methodology. Suggestions were made for the 11 key questions pertinent to diagnosis, biomarkers, antibiotics, and treatment strategies for adult patients with HAP/VAP. Using the CORE process and GRADE methodology, the committee generated a series of recommendations for HAP/VAP diagnosis and treatment in the Korean context.

摘要

医院获得性肺炎(HAP)和呼吸机相关性肺炎(VAP)与高发病率和死亡率相关。考虑当地流行病学数据的指南对于确定最佳治疗策略至关重要。然而,韩国尚无HAP/VAP指南。本研究由韩国结核病和呼吸疾病学会呼吸感染研究组的九位专家组成的委员会开展,采用了韩国HAP/VAP流行病学研究的结果。探讨了HAP/VAP诊断和治疗的11个关键问题。采用意见与证据融合(CORE)流程得出建议,证据水平和推荐等级符合推荐分级评估、制定与评价(GRADE)方法。针对成年HAP/VAP患者诊断、生物标志物、抗生素及治疗策略相关的11个关键问题提出了建议。该委员会采用CORE流程和GRADE方法,针对韩国国情制定了一系列HAP/VAP诊断和治疗的建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44f4/11704733/49438c38f182/trd-2024-0135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44f4/11704733/49438c38f182/trd-2024-0135f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44f4/11704733/49438c38f182/trd-2024-0135f1.jpg

相似文献

1
Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia.韩国成人医院获得性肺炎管理与抗生素治疗指南
Tuberc Respir Dis (Seoul). 2025 Jan;88(1):69-89. doi: 10.4046/trd.2024.0135. Epub 2024 Oct 11.
2
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).国际 ERS/ESICM/ESCMID/ALAT 医院获得性肺炎和呼吸机相关性肺炎管理指南:欧洲呼吸学会 (ERS)、欧洲重症监护医学学会 (ESICM)、欧洲临床微生物学和传染病学会 (ESCMID) 和拉丁美洲胸科协会 (ALAT) 医院获得性肺炎 (HAP)/呼吸机相关性肺炎 (VAP) 管理指南。
Eur Respir J. 2017 Sep 10;50(3). doi: 10.1183/13993003.00582-2017. Print 2017 Sep.
3
Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.诗里拉吉医院成人医院获得性肺炎和呼吸机相关性肺炎:病因、临床结局及抗菌药物耐药性的影响
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S126-38.
4
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.重症成年患者医院获得性肺炎的短疗程与长疗程抗生素治疗
Cochrane Database Syst Rev. 2015 Aug 24;2015(8):CD007577. doi: 10.1002/14651858.CD007577.pub3.
5
The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.成人重症监护病房获得性肺炎/呼吸机相关性肺炎中多重耐药微生物的分布和治疗状况:一项前瞻性队列观察研究。
J Korean Med Sci. 2021 Oct 25;36(41):e251. doi: 10.3346/jkms.2021.36.e251.
6
Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults.支持成人 HAP 和 VAP 治疗、诊断和预防国际指南推荐的证据。
Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):483-491. doi: 10.1007/s10096-019-03748-z. Epub 2019 Dec 10.
7
Review of health economic models exploring and evaluating treatment and management of hospital-acquired pneumonia and ventilator-associated pneumonia.医院获得性肺炎和呼吸机相关性肺炎的治疗和管理的健康经济模型的回顾与评估。
J Hosp Infect. 2020 Dec;106(4):745-756. doi: 10.1016/j.jhin.2020.09.012. Epub 2020 Sep 21.
8
The methodological quality of guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia: A systematic review.医院获得性肺炎和呼吸机相关性肺炎指南的方法学质量:一项系统评价。
J Clin Pharm Ther. 2018 Aug;43(4):450-459. doi: 10.1111/jcpt.12696. Epub 2018 May 2.
9
Characteristics, Management, and Clinical Outcomes of Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: A Multicenter Cohort Study in Korea.医院获得性肺炎和呼吸机相关性肺炎患者的特征、管理及临床结局:韩国一项多中心队列研究
Tuberc Respir Dis (Seoul). 2021 Oct;84(4):317-325. doi: 10.4046/trd.2021.0018. Epub 2021 Jun 4.
10
Prognosis of hospital-acquired pneumonia/ventilator-associated pneumonia with Stenotrophomonas maltophilia versus Klebsiella pneumoniae in intensive care unit: A retrospective cohort study.耐甲氧西林寡养单胞菌与肺炎克雷伯菌所致 ICU 获得性肺炎/呼吸机相关性肺炎的预后比较:一项回顾性队列研究。
Clin Respir J. 2022 Oct;16(10):669-676. doi: 10.1111/crj.13537. Epub 2022 Aug 31.

本文引用的文献

1
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.多黏菌素单药治疗与联合治疗耐碳青霉烯类微生物的比较
NEJM Evid. 2023 Jan;2(1). doi: 10.1056/evidoa2200131. Epub 2022 Dec 6.
2
Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea.比较韩国《维持生命治疗决定法》实施后医院获得性肺炎患者的临终决策。
BMC Med Ethics. 2023 Jul 18;24(1):52. doi: 10.1186/s12910-023-00931-y.
3
Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis.
非重症监护病房获得性肺炎的微生物学模式及临床结局:韩国医院获得性肺炎登记分析
Korean J Intern Med. 2023 May;38(3):450. doi: 10.3904/kjim.2021.348.e1. Epub 2023 Apr 24.
4
Progression of Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam or Cefepime in Sepsis-Associated Acute Kidney Injury.万古霉素与哌拉西林-他唑巴坦或头孢吡肟联用在脓毒症相关性急性肾损伤中导致肾损伤进展的情况
Front Nephrol. 2022;2. doi: 10.3389/fneph.2022.995358. Epub 2022 Oct 20.
5
Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.辅助雾化硫酸黏菌素治疗多重耐药革兰氏阴性菌肺炎的疗效和安全性:一项回顾性对比队列研究。
Ann Palliat Med. 2022 Sep;11(9):2939-2951. doi: 10.21037/apm-22-984.
6
Impact of nutrition and physical activity on outcomes of hospital-acquired pneumonia.营养与身体活动对医院获得性肺炎结局的影响。
Sci Rep. 2022 Sep 16;12(1):15605. doi: 10.1038/s41598-022-19793-2.
7
Piperacillin-Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?哌拉西林-他唑巴坦联合万古霉素相关的成人急性肾损伤:替考拉宁或其他抗假单胞菌β-内酰胺类药物能否作为补救措施?
Healthcare (Basel). 2022 Aug 20;10(8):1582. doi: 10.3390/healthcare10081582.
8
Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis.非 ICU 获得性肺炎的微生物学模式和临床结局:韩国 HAP 注册分析。
Korean J Intern Med. 2022 Jul;37(4):800-810. doi: 10.3904/kjim.2021.348. Epub 2022 Jun 28.
9
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.比较成人铜绿假单胞菌呼吸机相关性肺炎 8 天与 15 天抗生素治疗:一项随机、对照、开放标签试验。
Intensive Care Med. 2022 Jul;48(7):841-849. doi: 10.1007/s00134-022-06690-5. Epub 2022 May 13.
10
Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis.β-内酰胺单药治疗或联合治疗铜绿假单胞菌引起的血流感染或肺炎:一项荟萃分析。
Int J Antimicrob Agents. 2022 Mar;59(3):106512. doi: 10.1016/j.ijantimicag.2021.106512. Epub 2021 Dec 28.